H. Abrahamse University of Johannesburg Johannesburg (South Africa)
Prof. Abrahamse is presently serving as a Director in the Laser Research Center. She has been awarded a degree of PhD in Molecular Biology/Biochemistry from Wits University. Her research interests include photobiology and photochemistry with specific reference to photodynamic cancer therapy, nanotechnology and targeted cancer therapy investigating the intricate mechanisms underlying cancer cell death induced by novel photochemotherapeutic compounds in conjunction with the use of nanoparticles. Her international standing as a researcher of distinction is supported by the fact that she has hosted 3 international conferences and has been invited to present her research at several international conferences. Her publication record is impressive with 154 peer-reviewed accredited journal publications, 19 chapters and 3 books, and a Scopus H-index of 27.
A. Ahmadi Mazandaran University of Medical Sciences Sari (Iran)
Dr. Ahmadi is an experienced researcher with a demonstrated history of researching in the field of pharmaceutical sciences. He is skilled in clinical research, Animal models, Cellular models, Scientific writing & publishing. His research interest focuses on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many original and review articles in high-quality journals and selected as a recognized international editor and peer reviewer by famous publishers. In 2019, Dr. Amirhossein Ahmadi was placed in the top 1% of reviewers in Cross-Field on Publons global reviewer database.
A.M. Al-Abd Gulf Medical University Ajman (United Arab Emirates)
Dr. Al-Abd has been promoted in the fields of research/academia from research assistant to associate research professor at the National Research Centre of Egypt. He worked for 6 years as an Assistant/Associate Professor at King Abdul-Aziz University and supervised the research activities within the Tissue Culture facility in the Faculty of Pharmacy, King Abdul-Aziz University. He is currently an Associate Professor of Pharmaceutical Sciences at the Gulf Medical University, United Arab Emirates. In addition to his title, he is a visiting scholar in Bouvé College of Health Sciences, Northeastern University, USA.
D. Corina University of Medicine and Pharmacy "Victor Babes" Timisoara (Romania)
Dr. DANCIU CORINA is a Researcher, Pharmacist and the Head of Department of Pharmacognosy in Victor Babes University of Medicine and Pharmacy Timisoara. She has been awarded a degree of PhD in 2013. She has contributed her valuable 60 publications in different scientific journals. She is also a member of the editorial board of 6 international journals and co-author of patents. Her research interests include: quantitative and qualitative characterization of vegetal extracts, in vitro and in vivo evaluation of pure natural compounds or total extracts for different types of cancer, anti-inflammatory, antioxidant and antibacterial effect.
V. Das Palack University Olomouc (Czech Republic)
Dr. Viswanath Das is currently an Assistant Professor at Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc Czech Republic. He received his Bachelor’s and Master’s in biosciences and biotechnology from India after which he received his doctorate in Cell and Molecular Biology Victoria University of Wellington in 2012. His research interests include 3D cell cultures for better precision in drug discovery, repurposing of anti-cancer drugs for neurodegenerative diseases, mechanisms of tau misfolding, aggregation and spreading in tauopathies and the therapeutic efficacy of natural products and their metabolites. He has also received many awards and honors in the duration of his career for excellence.
I.H. Eissa Al-Azhar University Cairo (Egypt)
Ibrahim Hassan Eissa received his B.Sc. in 2003, Master’s degree in Medicinal Chemistry in 2009 and a PhD degree in 2012, both from the Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. Since 2017, he has been an Associate Professor of Medicinal Chemistry at the Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Al-Azhar University and was made a manager of QAU in 2018. His scientific activity is focused on design, molecular modelling studies and synthesis of new bioactive compounds with potential anticancer activity against EGFR, VEGFR-2, Topoisomerases, tubulins, Carbonic anhydrases, and thymidylate synthase.
J. Fang Nanjing University of Science and Technology Nanjing (China)
Dr. Jingkun Fang received both his B.Sc. and Ph.D. degrees from Hunan University in 2005 and 2010 respectively. During his Ph.D. period, he studied at the Okayama University of Science for 2 years under a joint Ph.D. program. After working in Changsha Research Institute of Mining and Metallurgy for nearly 3 years (2010-2013), he got a position as an associate professor at the Department of Chemistry in Nanjing University of Science and Technology (2013-present). He visited the Australian National University as a visiting scholar for 3 months in 2017. His research interests mainly focus on Organic Synthesis, Medicinal Chemistry, and Organic Functional Molecule.
J. Kim Kangwon National University Chuncheon-si (South Korea)
Prof. Jin-Chul Kim did his Ph.D. in Chemical Engineering from KAIST. In academic career, he spent more than 15 years in the College of Biomedical Science, Kangwon National University. His research interests include drug delivery systems, colloid & interface science, and polymer science developed to minimize the side effects of drugs and to maximize their efficacy. His researches are focused on the development of efficacious drug carriers, mostly working on carriers that release their contents in response to stimuli such as light, temperature, pH, current flow, magnetic field, and some specific substances. His publication record is impressive with more than 240 SCI-grade papers as the corresponding author.
M. Lin Taizhou People’s Hospital Jiangsu (China)
Dr Mei Lin is a Professor of Medical Science and holds a Doctor of Philosophy in Medicine. Her main research areas are nanomedicine, personalized diagnosis and therapy for cancer and tumour molecular imaging. Prof. Mei Lin is the academic leader of Jiangsu Key Clinical Specialty, the clinical laboratory of Taizhou People’s Hospital Affiliated to Nantong University. Her research work focuses on synthesis and characterization of Nano-drug and molecular probe, tumour molecular imaging, drug delivery, targeted therapy for cancer including chemotherapy, gene-therapy, magnetic thermotherapy and nuclide therapy.
T.S. Morais University of Lisbon Lisbon (Portugal)
Dr. Tânia Morais has been awarded a degree of PhD in Inorganic Chemistry in 2013 from the University of Lisbon. She was honored by the Portuguese Chemical Society in 2014 with the prize “Portuguese Young Chemist Award”. Currently, she is a researcher at Centro de Química Estrutural(CQE) at Faculdade de Ciências da Universidade de Lisboa (FCUL). Her research focuses on the design, synthesis and characterization of Ru, Fe and Cu complexes with targeting molecules (e.g. peptides, carbohydrates, and biomolecules) in their structure for the selective inhibition of the cancer development and metastases. She has 23 papers published in international journals, 3 book chapters and 3 patents.
P. Poltronieri Institute of Sciences of Food Productions, CNR-ISPA Bari (Italy)
Dr. Palmiro Poltronieri is presently serving as a researcher at the Agrofood Department of the Italian National Research Council. He holds a Ph.D. in Molecular and Cellular Biology from Verona University. His research interests include abiotic and biotic stress response in model plants, in bioactives from plants with a beneficial effect on health, in food microbiology and in the application of biocontrol strains for plant health. He is the co-founder of Biotecgen, a Small Medium Enterprise and service company, involved in European projects, such as RIBOREG, NANOMYC, ABSTRESS, and TOMGEM. He is Associate Editor to BMC Research Notes and is editor-in-chief for Challenges, an MDPI journal. He has co-authored 76 publications in international journals, 35 book chapters, and 5 books.
M. Scimeca University of Rome Tor Vergata Rome (Italy)
Dr. Manuel Scimeca, Biologist - Bachelor degree in "Cellular and molecular Biology" (2008); Masrer
degree in "Medical Biotechnology" (2011), PhD in "Medical Biotechnology and Translational Medicine"
(2015). Professor at University of Rome “Tor Vergata, “San Raffaele” University and “Saint Camillus
International University of Health and Medical Sciences”. Coordinator of Anatomic Pathology laboratory,
(University of Rome “Tor Vergata”) and Histology laboratory research (OrchideaLab). Post-Doc position
at University of Rome “Tor Vergata” for the project “Management of oncological patients”. Participant
in the European group of breast pathology studies. Member of the “Società Italiana di Anatomia
Patologica” (SIAPEC). Dr. Manuel Scimeca currently employs all basic and advanced techniques of the
histological area such as optical and electron microscopy, immunohistochemistry, in situ hybridization,
design and construction of Tissue Micro arrays (TMA), laser microdissection and capture.
O. TOKGÜN Pamukkale University
Dr. Onur received his Ph.D. in Medical Biology and Genetics from the Pamukkale Institute of Medical
Sciences in 2017. After completion of his degree he got the Assist. Prof. position in the Department
of Medical Genetics at the University of Pamukkale, Denizli/TURKEY. His interests are focused on
cancer genetics and biology. In particular his laboratory is currently working on understanding the
role of exosomes in tumorgenesis. Dr. Tokgun has published several research papers in scientific
Y. Tutar Cumhuriyet University Sivas (Turkey)
Prof. Yusuf TUTAR currently continues his research at the University of Health Sciences, Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Division of Biochemistry- Mektebi Tıbbiye-i Sahane, Turkey. He is also the head of the Molecular Medicine Program. He received his M.Sc. and Ph.D. at Oregon State University and Texas Tech University, respectively. He pursued his postdoctoral study at the National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of drug design, protein structure-function, protein folding, prion, microRNA, pseudogenes, molecular cancer, epigenetics, metabolites, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.
H. Xu University of Pennsylvania Perelman School of Medicine Philadelphia, PA (USA)
Dr Haineng Xu is currently a Postdoctoral Researcher at the Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. He received PhD in Biochemistry and Molecular Biology from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. His research areas include Oncolytic adenovirus, Cancer gene therapy, Cancer stem cells, and Small molecular drugs. Besides, he is a reviewer and editorial board member of several international journals. Also, he has published more than 20 papers in well-reputed international journals.
Q. Yan Zhejiang University Zhejiang (China)
Qiang Yan is a medical doctor, master supervisor, adjunct professor and FACS, Chairman of
Department of General Surgery at Zhejiang University Huzhou Hospital, Director of
Department of Hepatopancreatic and Biliary Surgery and Department of Surgery Teaching
and Research. He is a member of Committees of Biliary Surgeons, Department of Surgeons
and Hepatobiliary Minimal of Non-invasive Surgery, Chinese Medical Doctor Association and
many other academic associations. He is a Special Reviewer of Journals of Medicine,
Oncotarget; Special Member of Editorial Committees of Chinese Journal of General Surgery,
Liver Cancer and Chinese Journal of Clinicians, a participant of High Level Talents of
Zhejiang Medicine and Zhejiang Province 151 Talents.
L. Yang Affiliated Hospital of North Sichuan Medical College Sichuan (China)
Professor Lin Yang has received his B.S. in Clinical Medicine from Westchina Medical
University in 1990, M.S. in Surgery from Tianjin Medical University in 2001，and M.D. in
Imaging Medicine and Nuclear Medicine from Sichuan University in 2007, respectively. He
was employed as a professor of Imaging Medicine and Nuclear Medicine at Affiliated Hospital
of North Sichuan Medical College in 2012. Professor Lin Yang published about 80 journal
manuscripts, and seven academic books, respectively. He served as the Member of
Cardiovascular and Interventional Radiological Society of Europe (CIRSE), and Chinese
Society of Interventional Oncology; Deputy chairman of Sichuan Society of Interventional
Medicine, and Reviewers of J Vasc Interv Radiol, WJG, and Clinics, respectively.
Michelle Prudhomme Institut de Chimie de Clermont-Ferrand ICCF-CNRS UMR 6296 Université Clermont Auvergne Clermont-Ferrand (France)
Prof. Michelle Prudhomme holds the position of Emeritus Professor at the Blaise Pascal University of Clermont-Ferrand, France. She was awarded Doctor-Engineer degree at the University of Caen France where her research focused on the synthesis of sulfur compounds. Then she received her Ph.D. Degree at the University of Clermont-Ferrand, France, after works on antibiotics. She developed projects related to drug design and discovery of cytotoxic compounds. She has authored or co-authored 108 research and review articles and and 6 patents.
Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.